Tso-Ting Lai

Tso-Ting Lai

Auto-generated profile, based on publicly available information

Tso-Ting Lai

Department of Ophthalmology, National Taiwan University Hospital, Taipei 100, Taiwan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2015 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
TLTso-Ting Lai
Tso-Ting Lai
SCSan-Ni Chen
San-Ni Chen
CYChung-May Yang
Chung-May Yang

24 January 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TLTso-Ting Lai
Tso-Ting Lai
YHYi-Ting Hsieh
Yi-Ting Hsieh
CYChung-May Yang
Chung-May Yang
THTzyy-Chang Ho
Tzyy-Chang Ho
CYChang-Hao Yang
Chang-Hao Yang
This study evaluated the characteristic changes in optical coherence tomography (OCT) biomarkers in neovascular age-related macular degeneration (nAMD) treated with anti-vascular endothelial growth factor drugs and their relationship with visual outcomes at 1-year follow-up in a real-world setting. We retrospectively reviewed the medical records of 126 eyes with nAMD treated with either intravitreal ranibizumab or aflibercept, including ophthalmologic examinations and spectral-domain OCT at baseline and months 3, 6, and 12 after first injection. Treatment response of intraretinal cysts (IRCs), subretinal fluid (SRF), and pigment epithelial detachment (PED), and the correlation between best-corrected visual acuity (BCVA) changes and these OCT biomarkers were analyzed. After an average of 5.1 ± 1.5 injections, 33.3% of eyes with PED showed resolution at month 12, a significantly lower proportion than for IRCs (53.8%) or SRF (51.6%). BCVA improvement at 1 year was negatively associated with PED at baseline and with IRCs or PED at month 12. Persistence of IRCs at month 12 was associated with degeneration morphology of IRCs at baseline and non-resolved cysts at month 3 after loading. In conclusions, IRCs and PED are associated with poor visual improvement in nAMD in a real-world setting. Both IRCs and SRF responded better than PED to anti-VEGF therapy.

10 August 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
TLTso-Ting Lai
Tso-Ting Lai
CYChung-May Yang
Chung-May Yang
CYChang-Hao Yang
Chang-Hao Yang
Diabetic retinopathy (DR) is a major microvascular complication that can lead to severe visual impairment in patients with diabetes. The elevated oxidative stress and increased reactive oxygen species (ROS) production induced by hyperglycemia have been reported to play an important role in the complex pathogenesis of DR. Astaxanthin (AST), a natural carotenoid derivative, has been recently recognized as a strong free radical scavenger and might, therefore, be beneficial in different diseases, including DR. In this study, we evaluated the potential role of AST as an antioxidative and antiapoptotic agent in protecting retinal cells and also investigated the involvement of the PI3K/Akt/Nrf2 pathway in AST-mediated effects. We treated high glucose-cultured mouse photoreceptor cells (661W) with different concentrations of AST and analyzed ROS production and cell apoptosis in the different regimens. Moreover, we also analyzed the expression of PI3K, Akt, Nrf2, and Phase II enzymes after AST treatment. Our results showed that AST dose-dependently reduced ROS production and attenuated 661W cell apoptosis in a high glucose environment. Importantly, its protective effect was abolished by treatment with PI3K or Nrf2 inhibitors, indicating the involvement of the PI3K/Akt/Nrf2 pathway. These results suggest AST as a nutritional supplement that could benefit patients with DR.

1 June 2021 in Ophthalmology
Verified
Journal Article
Closed access
CTChia-Ying Tsai
Chia-Ying Tsai
PYPo-Ting Yeh
Po-Ting Yeh
PTPo-Nien Tsao
Po-Nien Tsao
YCYu-Chu Ella Chung
Yu-Chu Ella Chung
YCYu-Shan Chang
Yu-Shan Chang
TLTso-Ting Lai
Tso-Ting Lai

1 July 2018 in Retina
Verified
Journal Article
Closed access
PDF file
TLTso-Ting Lai
Tso-Ting Lai
CYChung-May Yang
Chung-May Yang
Purpose: To report findings and surgical outcomes of lamellar macular hole (LMH) or full-thickness macular hole (FTMH) accompanied by lamellar hole-associated epiretinal proliferation (LHEP) in eyes with high myopia (HM). Methods: Consecutive cases of HM with LMH or FTMH containing LHEP were retrospectively reviewed (study group, 43 cases). Cases of HM without LHEP (22) and those of non-HM with LHEP (30) served as Control A and B. Results: The study group showed larger (928.7 ± 381.9 μm) and deeper (remained base thickness: 79.7 ± 23.7 μm) LMH retinal defect than that in Control A (466.2 ± 179.1 and 99.9 ± 24.9) and B (647.1 ± 346.7 and 99.1 ± 38.1). Lamellar hole-associated epiretinal proliferation in the study group had a higher rate of wide extension (42.3%) and growing along the posterior hyaloid (PH, 53.8%). Patients with LMH who underwent surgery in the study group and Control A showed limited best corrected visual acuity (BCVA) improvement (0–1 and 1–2 ETDRS lines, respectively), while Control B had significant improvement (4–5 lines). For full-thickness macular holes, the study group was the youngest (50.0 ± 11.4) and LHEP was more likely to grow on the posterior hyaloid (23.5%); the postoperative best corrected visual acuity, however, was similar to that in Control A (20/63–20/80). Conclusion: Lamellar hole-associated epiretinal proliferation in HM tended to be more widespread and adherent to the posterior hyaloid than in eyes without HM. Visual outcomes after LMH repair in eyes with LHEP and HM are less favorable than eyes with LHEP and without HM, but similar to eyes with HM and without LHEP.

12 August 2019 in Eye
Verified
Journal Article
Closed access
PDF file
CHChia-Chieh Hsiao
Chia-Chieh Hsiao
CYChung-May Yang
Chung-May Yang
CYChang-Hao Yang
Chang-Hao Yang
THTzyy-Chang Ho
Tzyy-Chang Ho
TLTso-Ting Lai
Tso-Ting Lai
YHYi-Ting Hsieh
Yi-Ting Hsieh